AB017. SOH24AB_221. Trends in the prevalence and treatment of stone disease in the Irish hospitals

Background: The prevalence and incidence of urolithiasis are reported to be increasing across the world. The prevalence of urolithiasis in Ireland is unknown. We aim to determine the prevalence of urolithiasis in Ireland. Methods: Data were extracted from the Hospital In-Patient Enquiry (HIPE) system. Data assessed: number of procedures per age range (0–14, 15–44, 45–64 and 65+ years), number of day cases procedures, number of day inpatients procedures and the average length of stay. Population demographic data from 2005 to 2018 were obtained from the Central Statistics Office (CSO). Results: There were 74,874 admissions related to ureteric stones in Ireland from 2005 to 2018. Among them, 49,420 (66%) admissions were male, and 25,454 (34%) were female. A total of 33,687 (45%) procedures were day-case treatments. And, 1,300 (1.7%) patients were aged 0–14 years, 30,175 (40%) were aged 15–44 years, 31,070 (41%) were aged 45–64 years and 6,099 (8%) were 65+ years. In 2005, the period prevalence of ureteric stones in Ireland was 73.3/100,000; this increased to 141.6/100,000 by 2018. This is a 93% increase in urolithiasis in the 15-year period. Year on year, this represents a 5.2% increase. For males and female, in 2005, the period prevalence was 102.1/100,000 and 43.6/100,000 respectively. In 2018, the period prevalence for males was 184.5/100,000 and 100.2/100,000 females. In 2018, the period prevalence for 0–14 years is 10.4/100,000, 10.4/100,000 for 15–44 years, 260.9/100,000 for 45–64 years and 207.6/100,000 for 65+ years. The highest prevalence is 349.1/100,000 for males aged 45–64 years. Conclusions: These data suggest that the prevalence of kidney stones is increasing in Ireland. These increases are seen across sex and age. Future resource planning for urolithiasis will be needed to match the increase in demand.